Literature DB >> 10492399

Cloning and functional analysis of the human IRF-3 promoter.

W J Lowther1, P A Moore, K C Carter, P M Pitha.   

Abstract

We have isolated a genomic clone of the human IRF-3 gene containing 779 nucleotides of the 5' flanking region and the complete intron exon sequence. The gene has eight exons which span about 6 kb on chromosome 19q13.3. The IRF-3 promoter has neither a conserved TATA box nor a CCAAT box motif but is GC rich. Several putative DNA-binding elements were identified, including three SP-1 sites, a USF element, a HOX box, a CarG box, and an NF-1 site. Deletion analysis of the promoter region showed that the core basal promoter, consisting of 113 bp 5' of the first transcription start site, was sufficient for constitutive expression. This region contains only one of the SP-1 sites as well as the HOX element and NF-1 site, and although it is GC rich, it does not contain any of the other putative DNA-binding sites. In contrast, the mouse IRF-3 promoter, while displaying a high degree of homology with the human promoter, contains both TATA and CCAAT box motifs, suggesting that, at least at the level of transcription initiation, these genes may be differentially regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492399     DOI: 10.1089/104454999314962

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  14 in total

1.  Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene.

Authors:  A Y Karpova; P M Howley; L V Ronco
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

2.  Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1.

Authors:  Joel W Graff; Dana N Mitzel; Carla M Weisend; Michelle L Flenniken; Michele E Hardy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 3.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

4.  Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation.

Authors:  Oliver Bauhofer; Artur Summerfield; Yoshihiro Sakoda; Jon-Duri Tratschin; Martin A Hofmann; Nicolas Ruggli
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

5.  Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3.

Authors:  A Y Karpova; L V Ronco; P M Howley
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Direct repression of the human IRF-3 promoter by E2F1.

Authors:  Hua-Guo Xu; Wei Ren; Li Zou; Yi Wang; Rui Jin; Guo-Ping Zhou
Journal:  Immunogenetics       Date:  2011-01-12       Impact factor: 2.846

Review 7.  Anti-viral and anti-inflammatory mechanisms of the innate immune transcription factor interferon regulatory factor 3: relevance to human CNS diseases.

Authors:  Leonid Tarassishin; Avital Bauman; Hyeon-Sook Suh; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-10       Impact factor: 4.147

8.  Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1.

Authors:  Hua-Guo Xu; Wei Ren; Chao Lu; Guo-Ping Zhou
Journal:  Mol Biol Rep       Date:  2009-10-14       Impact factor: 2.316

9.  Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus.

Authors:  Zihong Chen; Rene Rijnbrand; Rohit K Jangra; Santhana G Devaraj; Lin Qu; Yinghong Ma; Stanley M Lemon; Kui Li
Journal:  Virology       Date:  2007-05-24       Impact factor: 3.616

10.  Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.

Authors:  Benjamin R tenOever; Sonia Sharma; Wen Zou; Qiang Sun; Nathalie Grandvaux; Ilkka Julkunen; Hiroaki Hemmi; M Yamamoto; Shizuo Akira; Wen-Chen Yeh; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.